These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8004839)

  • 21. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension.
    Rofman BA
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S94-7. PubMed ID: 2467139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive and metabolic effects of single and combined atenolol regimens.
    Chrysant SG; Chappel C; Farnham DJ; Levin B; Lueg M; McCluskey D; Steiner C
    J Clin Pharmacol; 1992 Jan; 32(1):61-5. PubMed ID: 1740538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
    Franco RJ; Goldflus S; McQuitty M; Oigman W;
    Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of guanabenz and hydrochlorothiazide on plasma lipids.
    Kaplan NM; Grundy S
    Clin Pharmacol Ther; 1988 Sep; 44(3):297-302. PubMed ID: 3046814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I; Hotnes T; Dollerup J; Mogensen CE
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Jordan J; Engeli S; Boye SW; Le Breton S; Keefe DL
    Hypertension; 2007 May; 49(5):1047-55. PubMed ID: 17353513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y; Lefebvre J; Provencher P; Poirier L
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
    Bhad P; Ayalasomayajula S; Karan R; Leon S; Riviere GJ; Sunkara G; Jarugula V
    J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
    Lacourcière Y; Taddei S; Konis G; Fang H; Severin T; Zhang J
    J Hypertens; 2012 Oct; 30(10):2047-55. PubMed ID: 22828090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
    Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
    J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.
    Christogiannis LG; Kostapanos MS; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS
    J Hum Hypertens; 2013 Jan; 27(1):44-50. PubMed ID: 22129607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
    Lewin AJ; Kereiakes DJ; Chrysant SG; Izzo JL; Oparil S; Lee J; Fernandez V; Melino M
    Ethn Dis; 2014; 24(1):41-7. PubMed ID: 24620447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
    Liu Y; Yan R; Song A; Niu X; Cao C; Wei J; Dong X; Gao D
    Am J Hypertens; 2014 Feb; 27(2):268-78. PubMed ID: 24304656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.